Ron Philip is Chief Commercial Officer of Spark Therapeutics and is responsible for leading commercial strategy & operations including marketing, sales, diagnostics, market access and patient services functions for inline products. He also manages commercial development activities for Spark’s late-stage pipeline assets. Ron has over 20 years of experience in the pharmaceutical industry with a proven track record of improving operating performance in multiple therapeutic categories and global markets.
Prior to joining Spark Therapeutics, he served in several senior leadership roles at Pfizer including Regional President – Africa Middle East, Head of Global Business Unit Strategy, Head of Business Development Search & Evaluation and Commercial Development within Pfizer’s Innovative Products Business. He previously worked at Wyeth Pharmaceuticals in U.S. commercial operations, with Deloitte Consulting in their strategy and operations practice and at Merck and Co. in the manufacturing and marketing divisions. Ron is an alumnus of Drexel University.